Renaissance Technologies LLC Sells 1206133 Shares of Immunomedics (IMMU)

Retrieved on: 2018-05-05 12:54:38

Tags for this article:

Money

Finance

Sacituzumab govitecan

Antibody-drug conjugate

Click the tags to see associated articles and topics

Renaissance Technologies LLC Sells 1206133 Shares of Immunomedics (IMMU). View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC decreased its position in shares of Immunomedics (NASDAQ:IMMU) by 84.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 230,474 shares of the ...</div>

Article found on:

View Original Article